<DOC>
	<DOCNO>NCT00236964</DOCNO>
	<brief_summary>The purpose study compare efficacy oral iron ( ferrous sulfate ) plus erythropoietin Iron Sucrose plus erythropoietin managing anemia patient chronic renal failure receive dialysis .</brief_summary>
	<brief_title>Comparison Oral Iron With IV Iron Patients With Anemia Chronic Renal Failure Not Dialysis</brief_title>
	<detailed_description>Randomized open-label multicenter active-controlled study anemic patient Chronic Renal Failure yet receive dialysis . The duration study five month . After screen procedure include multiple hemoglobin value , patient randomly assign either IV Iron Sucrose ( 200mg X 5 ) oral iron sulfate ( 325mg TID ) 29 day . Safety assessment include record adverse event , physical examination , vital sign , electrocardiograms clinical laboratory test . Efficacy parameter include hematologic parameter .</detailed_description>
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Iron</mesh_term>
	<mesh_term>Ferric oxide , saccharated</mesh_term>
	<mesh_term>Epoetin Alfa</mesh_term>
	<criteria>Creatine Clearance &lt; 40 mL/min Average Baseline Hemoglobin &lt; 10.5g/dL TSAT &lt; 25 % Ferritin &lt; 300ng/mL Blood Transfusion within 30days Uncontrolled Hypertension Suffering form concommitant disease liver Serious bacterial infection Pregnancy / lactation Symptomatic HIV Expected dialysis renal transplant study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2005</verification_date>
	<keyword>Anemia</keyword>
	<keyword>Chronic Kidney Disease</keyword>
</DOC>